Vaccines

29 May 2020 Johnson & Johnson Receives Positive CHMP Opinion for Janssen’s Investigational Preventive Ebola Vaccine Regimen
29 May 2020 Clinical Response and Translational Data from DeCidE1, a Phase 2 Study of DPX-Survivac Immunotherapy in Patients with Advanced Recurrent Ovarian Cancer
29 May 2020 Vaxxas Announces That Merck Exercises Option to Apply Novel Immune System Activation Platform for Vaccine Candidate
29 May 2020 GSK announces intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations
29 May 2020 AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company
28 May 2020 ImmunityBio & NantKwest Sign COVID-19 Joint Development, Manufacturing and Marketing Agreement; ImmunityBio Selected for ‘Operation Warp Speed’ to Develop Novel Adenovirus COVID-19 Vaccine
28 May 2020 Stallergenes Greer and Anergis Report Successful Preclinical Study Results With COP-virosomes as Second-generation Allergen Immunotherapy
26 May 2020 IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2
26 May 2020 Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
21 May 2020 IMV Announces Selection of a Vaccine Candidate Against COVID-19 to Advance Into Human Clinical Studies
21 May 2020 CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine
21 May 2020 AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
20 May 2020 Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate
20 May 2020 INOVIO’s COVID-19 DNA vaccine INO-4800 demonstrates robust neutralizing antibody and T cell immune responses in preclinical models
19 May 2020 PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology
19 May 2020 Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate
18 May 2020 GreenLight Biosciences raises $17M financing round to accelerate large-scale manufacturing of future COVID-19 vaccines
18 May 2020 Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
15 May 2020 Medicago Announces Positive Results in Animal Trials for Its Vaccine Candidate Against COVID-19
14 May 2020 INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo® (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following Treatment
14 May 2020 Pfizer Announces Positive Top-Line Results From Phase 3 Lot Consistency Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naive Adults 18 Through 49 Years of Age
14 May 2020 CureVac´s Optimized mRNA Platform Provides Positive Pre-Clinical Results at Low Dose for Coronavirus Vaccine Candidate
14 May 2020 VAXIMM Announces First Results from Phase I/II Trial in Progressive Glioblastoma with Oral T-cell Immunotherapy VXM01 in Combination with PD-L1 Inhibitor Avelumab to be Presented at ASCO20 Virtual
12 May 2020 Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
11 May 2020 TolerogenixX Reports Positive Phase Ib Data of its Lead Product to Combat Transplant Rejection

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top